ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs

This report, issued by the ACVIM Specialty of Cardiology consensus panel, revises guidelines for the diagnosis and treatment of myxomatous mitral valve disease (MMVD, also known as endocardiosis and degenerative or chronic valvular heart disease) in dogs, originally published in 2009. Updates were m...

Descripción completa

Detalles Bibliográficos
Autores principales: Keene, Bruce W., Atkins, Clarke E., Bonagura, John D., Fox, Philip R., Häggström, Jens, Fuentes, Virginia Luis, Oyama, Mark A., Rush, John E., Stepien, Rebecca, Uechi, Masami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Consensus Statements
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524084/
https://www.ncbi.nlm.nih.gov/pubmed/30974015
http://dx.doi.org/10.1111/jvim.15488
Descripción
Sumario:This report, issued by the ACVIM Specialty of Cardiology consensus panel, revises guidelines for the diagnosis and treatment of myxomatous mitral valve disease (MMVD, also known as endocardiosis and degenerative or chronic valvular heart disease) in dogs, originally published in 2009. Updates were made to diagnostic, as well as medical, surgical, and dietary treatment recommendations. The strength of these recommendations was based on both the quantity and quality of available evidence supporting diagnostic and therapeutic decisions. Management of MMVD before the onset of clinical signs of heart failure has changed substantially compared with the 2009 guidelines, and new strategies to diagnose and treat advanced heart failure and pulmonary hypertension are reviewed.

Ejemplares similares